Stromal Therapeutics
Basel
About Stromal Therapeutics
Stromal Therapeutics is the first biotechnological spin-off from the Kantonsspital St.Gallen. Stromal Therapeutics Building on the group’s unique domain expertise, the company has deployed state-of-the-art single-cell sequencing of human tissues to molecularly unravel the interplay of stromal tissue cytokines with the immune system
Company Facts
- Operating status: Active
- Company type: For Profit
- IPO status: Private
- Employees: 1 – 10
- Total funding: $536.9K
- Funding stage: Seed
- Last round: Seed (Jan 2022)
- Website: stromaltherapeutics.ch
- Phone: [email protected]
Industries & Categories
Biotechnology, Therapeutics
Canonical: https://fsome.com/organization/stromal-therapeutics-193460 · For the full interactive profile (charts, investors, team, acquisitions, press), please enable JavaScript.